Objective
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS), driven by autoreactive T cells that attack myelin and trigger relapsing-remitting inflammation and progressive neurodegeneration. Current therapies rely on systemic immunosuppression, which mitigates disease activity but fails to restore antigen-specific tolerance, underscoring the urgent need for site-specific reprogramming within the CNS. As brain border regions, including the choroid plexus (ChP) and ventricular interfaces, serve as key immune gateways for T cell trafficking within the CNS, we hypothesize local antigen presenting cells (APCs) can reprogram T cells. Among these APCs, Kolmer cells, recently characterized microglia-like cells at the ChP epithelium, represent an unexplored regulatory population with unique potential to modulate adaptive immunity at CNS entry sites. The LipoTAME project seeks to establish a first-in-class therapeutic strategy to induce local, antigen-specific tolerance by targeting Kolmer cells and paraventricular microglia with engineered lipid nanoparticles (LNPs). LNPs will carry nucleoside-modified mRNA encoding myelin antigens and tolerogenic cytokines, with the goal of reprogramming myeloid–T cell interactions and restoring regulatory T cell (Treg) function. In vivo proof-of-concept data from the host lab confirm efficient uptake of intraventricular LNPs by myeloid cells, demonstrating the approach’s feasibility. By integrating nanomedicine and neuroimmunology, LipoTAME aims to restore CNS-targeted immune tolerance in MS, with broad potential across autoimmune diseases. My expertise in ChP biology, including barrier properties and resident immune populations across health and disease, combined with Movahedi Lab’s cutting-edge platforms in CNS-targeted immunology and single-cell –omics, provides a strong foundation for LipoTAME to explore this novel approach and advance CNS-targeted immunotherapies.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- engineering and technology electrical engineering, electronic engineering, information engineering electrical engineering power engineering electric power generation combined heat and power
- medical and health sciences basic medicine immunology immunotherapy
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-MSCA-2025-PF
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
1050 Bruxelles / Brussel
Belgium
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.